Grupo de Investigación en Fertilidad
GINFER
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (13)
2024
-
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 35, Núm. 3, pp. 248-266
-
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer
Bulletin du Cancer, Vol. 111, Núm. 3, pp. 277-284
2023
2022
-
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
American Journal of Obstetrics and Gynecology, Vol. 227, Núm. 5, pp. 735.e1-735.e25
2021
-
European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery
International Journal of Gynecological Cancer, Vol. 31, Núm. 9, pp. 1199-1206
-
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)
Cancer Medicine, Vol. 10, Núm. 1, pp. 208-219
-
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic
British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96
2019
-
Oncological outcome of surgical management in patients with recurrent uterine cancer - A multicenter retrospective cohort study - CEEGOG EX01 Trial
International Journal of Gynecological Cancer, Vol. 29, Núm. 4, pp. 711-720
2018
-
HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?
Annals of Oncology
-
Is there a role for HIPEC in ovarian cancer?
Archives of Gynecology and Obstetrics
2017
-
Brief Report about the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer from Spiliotis et al
International Journal of Gynecological Cancer, Vol. 27, Núm. 2, pp. 246-247
-
Value of neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer: A European perspective
Journal of Clinical Oncology
2016
-
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
Annals of Oncology, Vol. 27, Núm. 1, pp. 16-41